| __timestamp | BioMarin Pharmaceutical Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 2917513 |
| Thursday, January 1, 2015 | 402271000 | 7878291 |
| Friday, January 1, 2016 | 476593000 | 8366794 |
| Sunday, January 1, 2017 | 554336000 | 6610381 |
| Monday, January 1, 2018 | 604353000 | 6556000 |
| Tuesday, January 1, 2019 | 680924000 | 6930000 |
| Wednesday, January 1, 2020 | 737669000 | 8758000 |
| Friday, January 1, 2021 | 759375000 | 10806000 |
| Saturday, January 1, 2022 | 854009000 | 9844000 |
| Sunday, January 1, 2023 | 937300000 | 13481000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc. have shown contrasting approaches to handling these costs.
BioMarin, a leader in the biotech industry, has seen its SG&A expenses grow steadily, reaching a peak in 2023. This represents a significant increase of over 200% since 2014. In contrast, Soleno Therapeutics, a smaller player, has managed to keep its SG&A expenses relatively stable, with only a modest increase of around 360% over the same period.
While BioMarin's larger scale justifies its higher expenses, Soleno's ability to maintain cost efficiency is noteworthy. This comparison highlights the different strategies employed by large and small pharmaceutical companies in managing operational costs.
Bristol-Myers Squibb Company vs Soleno Therapeutics, Inc.: SG&A Expense Trends
Biogen Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Neurocrine Biosciences, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Incyte Corporation and BioMarin Pharmaceutical Inc.
Incyte Corporation and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
BioMarin Pharmaceutical Inc. vs Exelixis, Inc.: SG&A Expense Trends
BioMarin Pharmaceutical Inc. or Corcept Therapeutics Incorporated: Who Manages SG&A Costs Better?
BioMarin Pharmaceutical Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Grifols, S.A. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Soleno Therapeutics, Inc. and Travere Therapeutics, Inc.